http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
A Case Primary Osteosarcoma Originating in the Sacrum
Park, Eun-Joo,Ahn, Myung-Ju,Rhu, Jun-Ho,Shin, Sung-Jun,Wi, Hyung-Jung,Choi, Jung-Hye,Lee, Young-Yeol,Jung, Tae-Joon,Choi, Il-Young,Kim, Im-Soon 한양대학교 의과대학 2000 한양의대 학술지 Vol.20 No.2
골육종은 주로 장관골의 골 성장 부위인 골간단(metaphysis)에 주로 발생하며 경골 근위부, 대퇴골 원위부 및 상완골 근위부가 호발 부위인 것으로 알려져 있다. 편평골인 천골에 발생한 예는 극히 드물고, 또한 원발성 보다는 Paget's disease나 국소적 방사선 요법 후 속발성으로 발생했던 경우가 많은 것으로 알려져 있다. 사지에 발생한 골육종에서는 술전 및 술후의 항암 화학 요법과 수술을 포함한 현재 치료 전략으로 60-70%의 장기 생존률을 보이고 있는 반면, 천골에서 발생한 골육종은 위치상 넓은 변연을 가지고 있어 종양 절제가 용이하지 않고, 절제 시 주위의 내부장기, 교감 및 부교감 신경 손상이 많으며, 또한 전이의 위험도가 높아서 불량한 예후를 보이고 있다. 이 병변의 희소성 때문에 수술적인 발전이 어려웠고 사지 골육종의 치료 경험의 적용에 대한 종양학적인 성과가 현재도 확립되지 못한 상태이다. 이에 저자들도 원발성 골육종이 천골에 침범한 1예를 경험하였기에 보고하는 바이다.
( Hye Ju Yeo ),( Soo Yong Lee ),( Eunyoung Ahn ),( Eun Jung Kim ),( Dae Gon Rhu ),( Kyoung Un Choi ),( Seung Eun Lee ),( Woo Hyun Cho ),( Doo Soo Jeon ),( Yun Seong Kim ) 대한결핵 및 호흡기학회 2013 Tuberculosis and Respiratory Diseases Vol.75 No.5
This report describes a rare case of a patient with splenic tuberculosis (TB) who developed spontaneous splenic rupture after 10 weeks of antituberculous chemotherapy. The patient responded well to the antituberculous regimen prior to the spontaneous splenic rupture. We considered a paradoxical reaction as a cause of the splenic rupture. The patient underwent splenectomy and continuously received initial antituberculous drugs without change. To the best of our knowledge, this is the first report of spontaneous splenic rupture as a paradoxical reaction to antituberculous chemotherapy in an immunocompetent host with splenic TB.
Oh Young Ju,Kim Jongman,Kang Eun-Suk,Rhu Jinsoo,Choi Gyu-Seong,Joh Jae-Won 대한의학회 2023 Journal of Korean medical science Vol.38 No.16
Background: Liver transplant (LT) recipients were considered a vulnerable population during the coronavirus disease 2019 (COVID-19) pandemic. The clinical efficacy of the COVID-19 vaccine is unknown in immunocompromised patients. The purpose of this study was to provide evidence of antibody responses after COVID-19 vaccination in LT recipients. Methods: This study enrolled 46 patients who underwent LT at Samsung Medical Center (Seoul, Korea) before implementation of the one-dose vaccine in Korea. Those who completed the two-dose COVID-19 vaccine between August 2021 and September 2021 were included and followed through December 2021. Semiquantitative anti-spike serologic testing was performed using the Roche Elecsys anti-SARS-CoV-2 S enzyme immunoassay (Roche Diagnostics, Rotkereuz, Switzerland) with a positive cutoff of at least 0.8 U/mL. Results: Among all 46 participants, 40 (87%) demonstrated an antibody response after the second dose of a COVID-19 vaccine, while six (13%) had no antibody response after the second dose. Upon univariate analysis, patients with higher antibody titer had longer years since LT (2.3 ± 2.8 vs. 9.4 ± 5.0, P < 0.001). A lower median tacrolimus (TAC) level before vaccination and after the second dose of COVID-19 vaccine indicated a significantly higher antibody response (2.3 [1.6–3.2] vs. 7.0 [3.7–7.8], P = 0.006, 2.5 [1.6–3.3] vs. 5.7 [4.2–7.2], P = 0.003). Period between 2nd vaccination and serologic testing was significantly higher in the antibody-response group compared to the no-antibody-response group (30.2 ± 24.0 vs. 65.9 ± 35.0, P = 0.012). A multivariate analysis of antibody responses revealed TAC level before vaccination as a statistically significant factor. Conclusion: A higher TAC level before vaccination resulted in less effective vaccination in LT patients. Booster vaccinations are required, especially for patients in the early stage after LT who have compromised immune function.
Spontaneous Splenic Rupture as a Paradoxical Reaction during Treatment for Splenic Tuberculosis
Yeo, Hye Ju,Lee, Soo Yong,Ahn, Eunyoung,Kim, Eun Jung,Rhu, Dae Gon,Choi, Kyoung Un,Lee, Seung Eun,Cho, Woo Hyun,Jeon, Doosoo,Kim, Yun Seong The Korean Academy of Tuberculosis and Respiratory 2013 Tuberculosis and Respiratory Diseases Vol.75 No.5
This report describes a rare case of a patient with splenic tuberculosis (TB) who developed spontaneous splenic rupture after 10 weeks of antituberculous chemotherapy. The patient responded well to the antituberculous regimen prior to the spontaneous splenic rupture. We considered a paradoxical reaction as a cause of the splenic rupture. The patient underwent splenectomy and continuously received initial antituberculous drugs without change. To the best of our knowledge, this is the first report of spontaneous splenic rupture as a paradoxical reaction to antituberculous chemotherapy in an immunocompetent host with splenic TB.